Quantitative Analysis of Polysorbate 20/80 in Protein-Based Biopharmaceuticals Using A One-Pot RPLC-MS Based Platform Method

Significance of the Topic

Polysorbate 20 and 80 are widely used surfactants in biopharmaceutical formulations to prevent protein aggregation, denaturation, and adsorption losses. Accurate quantitation of these excipients is critical for assessing drug stability, shelf life, and patient safety, as degradation pathways such as oxidative, hydrolytic, and enzymatic cleavage can compromise product efficacy.

Study Objectives and Overview

This work presents a one-pot, high-throughput RPLC-MS platform for quantifying polysorbate 20 and 80 in protein drug products. The method combines base hydrolysis, rapid methylation of liberated fatty acids, reversed-phase separation on a C8 column, and single-quadrupole MS detection to achieve sub-ppm sensitivity and enhanced specificity.

Methodology and Instrumentation

The sample preparation integrates:

• Base hydrolysis: 0.5 M NaOH at 65 °C for 18 hours to cleave ≥ 95 % of sorbitan ester linkages
• Methanolysis/methylation: 8 % HCl in methanol at 100 °C for 1 hour, boosting MS response tenfold
• Liquid–liquid extraction: hexane/water partitioning, with a single 0.5 mL hexane aliquot sufficient for analysis (recovery ≈ 99 %)

The LC-MS conditions include an ACQUITY UPLC H-Class PLUS Bio system with BEH C8 column (2.1 × 100 mm, 1.7 μm), 75–100 % MeCN gradient, 0.2 mL/min flow, and ACQUITY QDa mass detector in positive SIR mode (m/z 131–383). Empower 3 software manages data acquisition.

Key Results and Discussion

Chromatographic optimization on C8 stationary phase delivered baseline separation of methylated fatty acids within 10–18 minutes, outperforming traditional ELSD/CAD methods. Hydrolysis kinetics confirmed > 95 % conversion after 18 hours. Methylation reduced in-source water loss (< 5 % vs. ≥ 50 %) and improved proton affinity, yielding a tenfold sensitivity increase in positive mode. Extraction trials demonstrated near-complete recovery and negligible carry-over. Calibration curves built from raw polysorbate material showed excellent linearity (R² > 0.999), and analysis of commercial biopharmaceutical samples yielded 152 ± 2 ppm PS-20 and 242 ± 6 ppm PS-80.

Benefits and Practical Applications

• Platform scalability and ease of deployment across formulation, development, and QC labs
• Enhanced sensitivity and specificity via MS detection, reaching sub-ppm levels
• Minimal, one-pot sample preparation reducing handling and reagent use
• Flexible sample volume adjustments to accommodate variable polysorbate concentrations

Future Trends and Applications

Further developments may include reaction time reduction through optimized catalysts, automation of the one-pot workflow, adaptation to high-resolution MS for detailed structural profiling, extension to other non-volatile surfactants, and integration into continuous process analytical technology (PAT) for real-time monitoring in biomanufacturing.

Conclusion

The described one-pot RPLC-MS hydrolysis and methylation platform offers a robust, scalable, and highly sensitive solution for quantitative analysis of polysorbate 20 and 80 in biopharmaceutical drug products. Its combination of minimal sample handling, rapid separation, and single-quad mass detection provides a valuable tool for ensuring drug safety and stability.

References

1. Birdsall RE, Dao D, Koshel BM, Yu YQ, Smeets A, Gerodez M, Taillieu X. Quantitative Analysis of Polysorbate 20/80 in Protein-Based Biopharmaceuticals Using a One-Pot RPLC-MS Based Platform Method. Waters Corp; GlaxoSmithKline.
2. Kerwin B. Polysorbate 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways. J Pharm Sci. 2007;97(8):2924–2935.
3. Honemann M, Wendler J, Graf T, Bathke A, Bell C. Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method. J Chromatogr B. 2019;1116:1–8.
4. Labrenz S. Ester Hydrolysis of Polysorbate 80 in mAb Drug Product: Evidence in Support of the Hypothesized Risk After the Observation of Visible Particulate in mAb Formulations. J Pharm Sci. 2014;103:2268–2277.
5. Hewitt D, Zhang T, Kao T. Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection. J Chromatogr A. 2008;1215:156–160.
6. Ilko D, Braun A, Germershaus O, Meinel L, Holzgrabe U. Fatty acid composition analysis in polysorbate 80 with high performance liquid chromatography coupled to charged aerosol detection. Eur J Pharm Biopharm. 2015;94:569–574.
7. Ichihara K, Fukubayashi Y. Preparation of fatty acid methyl esters for gas-liquid chromatography. J Lipid Res. 2009;50(Suppl):S213–S218.